ADispell, Inc

A platform technology for drug development has produced positive in vivo results treating cognition/memory loss while also treating anxiety.

  • Stage Product In Development
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded January 2009
  • Employees 4
  • Incorporation Type C-corp
  • Website adispell.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free